Oramed to transfer POD platform to Lifeward for 49.9% beneficial ownership; invests $18M in convertible notes

ORAMED PHARMACEUTICALS INC.

Oramed to receive up to 49.9% beneficial ownership in Lifeward via shares, pre-funded warrants, plus 4% revenue sharing on ReWalk net sales (max 10 years).
Oramed to invest $9M initial plus $9M milestone-based in 8% senior secured convertible notes convertible at $0.45/sh with 100% warrant coverage.
Lifeward's ReWalk and AlterG products generated $26M revenue in trailing four quarters; CEO Mark Grant has 25+ yrs diabetes experience (Medtronic, BMS).
Transaction requires Lifeward shareholder approval for >19.99% issuance; Oramed to manage clinical trial of oral insulin capsule.
Combines Oramed's oral drug delivery platform with Lifeward's medical robotics; Oramed retains exposure to both platforms.

item 1.01 item 8.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

ORAMED PHARMACEUTICALS INC. entered into Share Purchase Agreement with Lifeward Ltd. (effective 2026-01-12).

Action: entry
Agreement: asset purchase
Counterparty: Lifeward Ltd.
Effective: 2026-01-12

Exact text from the filing

On January 12, 2026, Oramed Pharmaceuticals Inc. (the “Company”) entered into that certain Share Purchase Agreement (“Share Purchase Agreement”), by and among the Company, Lifeward Ltd. (“Lifeward”) and Oratech Pharma, Inc., the Company’s wholly-owned subsidiary (“Oratech”).

View on SEC.gov

301 material agreements filed in the last 30 days. Browse all material agreements →

ORAMED PHARMACEUTICALS INC. filing history →

Source: SEC EDGAR

accession 0001213900-26-004382

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.